Suppr超能文献

消化道癌症患者外周血T淋巴细胞中Th2亚群占优势

Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers.

作者信息

Tabata T, Hazama S, Yoshino S, Oka M

机构信息

Department of Surgery II, Yamaguchi University School of Medicine, Ube, Japan.

出版信息

Am J Surg. 1999 Mar;177(3):203-8. doi: 10.1016/s0002-9610(99)00004-5.

Abstract

BACKGROUND

Two types of helper T cells (Th), which are categorized as Th1 and Th2 on the basis of cytokine production, have been reported. Th1 cells produce interleukin (IL)-2 and interferon (IFN)-gamma, while Th2 cells secrete IL-4, IL-6, and IL-10. We assessed the intracellular cytokine profiles of CD3/CD4 positive lymphocytes (CD4+ T-cells) in peripheral blood in patients with digestive cancers.

METHODS

Peripheral blood samples were collected from 50 patients with digestive cancers and 35 healthy volunteers. The proportions of CD4+ T-cells producing intracellular cytokines were determined using flow cytometry.

RESULTS

The percentages (mean +/- SD) of CD4+ T-cells producing IL-4, IL-6, and IL-10 in the cancer group (73.9% +/- 13.0%, 73.0% +/- 16.6%, and 58.0% +/- 21.0%, respectively) were significantly higher than in the healthy group (37.4% +/- 12.4%, 37.8% +/- 13.5%, and 34.0% +/- 14.1%, respectively; P <0.01). Proportions of CD4+ T-cells producing IL-4, IL-6, and IL-10 in 10 patients undergoing curative resection had decreased significantly 1 month after surgery (P <0.01). No significant difference was noted between groups in the percentages of CD4+ T-cells producing IFN-gamma.

CONCLUSIONS

Th2-dominant status develops in cancer patients. Such lymphocyte evaluations could find applications in diagnosis and therapeutic monitoring of cancer patients.

摘要

背景

据报道,基于细胞因子的产生可将辅助性T细胞(Th)分为两种类型,即Th1和Th2。Th1细胞产生白细胞介素(IL)-2和干扰素(IFN)-γ,而Th2细胞分泌IL-4、IL-6和IL-10。我们评估了消化系统癌症患者外周血中CD3/CD4阳性淋巴细胞(CD4+T细胞)的细胞内细胞因子谱。

方法

采集50例消化系统癌症患者和35名健康志愿者的外周血样本。使用流式细胞术测定产生细胞内细胞因子的CD4+T细胞比例。

结果

癌症组中产生IL-4、IL-6和IL-10的CD4+T细胞百分比(平均值±标准差)分别为73.9%±13.0%、73.0%±16.6%和58.0%±21.0%,显著高于健康组(分别为37.4%±12.4%、37.8%±13.5%和34.0%±14.1%;P<0.01)。10例行根治性切除的患者术后1个月产生IL-4、IL-6和IL-10的CD4+T细胞比例显著下降(P<0.01)。两组之间产生IFN-γ的CD4+T细胞百分比无显著差异。

结论

癌症患者呈现Th2优势状态。此类淋巴细胞评估可应用于癌症患者的诊断和治疗监测。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验